Johnson & Johnson Plans Virtual Clinical Trial, Builds On Apple Heart Study Results

Johnson & Johnson (JNJ), one of the most recognized names in healthcare, announced in January a collaborative study with Apple to detect AFib, and more study details were released at ACC. Called HEARTLINE, the study plans to enroll up to 150,000 Americans 65 and older, a population with higher risk and prevalence of AFib.